永赢医药创新智选混合发起C(015916)份额变动
截止日 |
期初份额(份) |
期末份额(份) |
期间申购份额(份) |
期间赎回份额(份) |
2024-12-30 |
227,249,007.18 |
162,708,692.74 |
192,547,016.16 |
257,087,330.60 |
2024-09-29 |
259,336,823.59 |
227,249,007.18 |
158,678,242.46 |
190,766,058.87 |
2024-06-29 |
241,672,649.54 |
259,336,823.59 |
190,638,651.42 |
172,974,477.37 |
2024-03-30 |
275,661,520.37 |
241,672,649.54 |
169,500,837.79 |
203,489,708.62 |
2023-12-30 |
167,899,340.68 |
275,661,520.37 |
321,138,587.85 |
213,376,408.16 |
2023-09-29 |
146,730,188.38 |
167,899,340.68 |
161,666,548.78 |
140,497,396.48 |
2023-06-29 |
40,013,333.86 |
146,730,188.38 |
266,360,202.19 |
159,643,347.67 |
2023-03-30 |
1,082,902.93 |
40,013,333.86 |
68,515,595.58 |
29,585,164.65 |
2022-12-30 |
742,493.89 |
1,082,902.93 |
825,162.22 |
484,753.18 |